Building a National Framework for the Establishment of Regulatory Science for Drug Development: Workshop Summary
Book information
Description
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it.
Similar books
Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary
2015 · EPUB
Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders: Workshop Summary
2015 · EPUB
Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary
2012 · EPUB
Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing an Agenda for 2020: Workshop Summary
2012 · EPUB
Adverse Drug Event Reporting: The Roles of Consumers and Health-Care Professionals: Workshop Summary
2007 · EPUB
Large Simple Trials and Knowledge Generation in a Learning Health System : Workshop Summary
2014 · EPUB
Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development : Workshop Summary
2012 · EPUB
Transforming Clinical Research in the United States : Challenges and Opportunities: Workshop Summary
2010 · PDF